Open access
Open access
Powered by Google Translator Translator

Archives

Perspective: When Science Needs Self-Correcting

27 Mar, 2020 | 03:36h | UTC

When Science Needs Self-Correcting – Medium (free)

“Admitting scientific errors is hard. It’s also important.”

 


ESMO Guideline: Cancer-related Fatigue

27 Mar, 2020 | 03:34h | UTC

Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment – Annals of Oncology (free PDF)

Commentary: ESMO updates cancer-related fatigue recommendations – Medicine Matters (free)

 


[Abstract Only] Study: Global Incidence Trends in Primary Liver Cancer by Age at Diagnosis, Sex, Region, and Etiology

27 Mar, 2020 | 03:32h | UTC

Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990‐2017 – Cancer (link to abstract – $ for full-text)

Commentary: Liver cancer incidence in older adults up 50% globally since 1990 – UPI

 


Study: Prevalence and Outcomes of Infection Among Patients in Intensive Care Units

27 Mar, 2020 | 03:28h | UTC

Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017 – JAMA (free for a limited period)

Editorial: Infection, Antibiotics, and Patient Outcomes in the Intensive Care Unit (free for a limited period)

Commentary: Multinational ICU study finds high rate of infection, antibiotic use – CIDRAP (free)

 


Cohort Study: Multicenter Emergency Department Validation of the Canadian Syncope Risk Score

27 Mar, 2020 | 03:21h | UTC

Multicenter Emergency Department Validation of the Canadian Syncope Risk Score – JAMA Internal Medicine (free for a limited period)

Commentary: Emergency Department Validation of Canadian Syncope Risk Score – American College of Cardiology

 


Randomized Trial: Acupuncture Reduces Frequency of Migraine Days and Migraine Attacks

27 Mar, 2020 | 03:20h | UTC

Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial – The BMJ (free)

Editorial: Manual acupuncture for migraine – The BMJ (free)

Commentary: Does acupuncture relieve migraines? – News Medical (free)

 


Thu March 26 – 10 Stories of The Day!

26 Mar, 2020 | 02:30h | UTC

 

1 – Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment – Imperial College London (PDF)

See also: Summary

Commentaries: Initial success for COVID-19 social distancing in China – Imperial College London AND China shows way to ease lockdowns before vaccine, says report – The Guardian AND When can we let up? Health experts craft strategies to safely relax coronavirus lockdowns – STAT

Related: What China’s coronavirus response can teach the rest of the world – Nature AND Locked-down no longer, China’s Hubei begins return to normal – Reuters AND The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study – The Lancet Public Health

 

2 – The effect of human mobility and control measures on the COVID-19 epidemic in China – Science

News Release: Travel restrictions are most useful in the early and late phase of an epidemic – University of Oxford

 

3 – What do we know about the risk of dying from COVID-19? – Our World in Data

Related: Global Covid-19 Case Fatality Rates – Centre for Evidence-Based Medicine, University of Oxford (free)

 

4 – Studies: Cardiac Injury Associated to Increased Mortality in Hospitalized Patients With COVID-19

 

5 – Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline – Neurology (PDF)

Commentary: Study: An aspirin a day does not keep dementia at bay – American Academy of Neurology (free)

 

6 – Prolonged presence of SARS-CoV-2 viral RNA in faecal samples – The Lancet Gastroenterology & Hepatology

“Very important article about viral shedding. Spoiler alert: quarantine may need to be much longer than 14 days. Virus is detectible in feces for up to 5 weeks. Caveat: virus not necessarily viable” (via @figgyjam see Tweet)

 

7 – Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients – Ophthalmology

Commentary: Low risk of coronavirus spreading through tears – American Academy of Ophthalmology

 

8 – Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19) – World Health Organization

 

9 – Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents – The Journal of Hospital Infection

Commentaries: Coronavirus: household cleaning products can kill the virus – an expert on which ones to use – The Conversation AND One graphic shows how long the coronavirus lives on surfaces like cardboard, plastic, and steel – Business Insider

Related Study: Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 – New England Journal of Medicine

 

10 – Coronavirus Disease (COVID-19) Updates / 26 March 2020 Edition

26 March 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Artificial Intelligence vs. Clinicians: Systematic Review of Design, Reporting Standards, and Claims of Deep Learning Studies

27 Mar, 2020 | 03:14h | UTC

Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies – The BMJ (free)

Commentary: Claims AI outperforms doctors ‘exaggerated’ – OnMedica (free)

 


Study: Travel Restrictions are Most Useful in the Early and Late Phase of an Epidemic

26 Mar, 2020 | 02:25h | UTC

The effect of human mobility and control measures on the COVID-19 epidemic in China – Science

News Release: Travel restrictions are most useful in the early and late phase of an epidemic – University of Oxford

 


Report: Evidence of Initial Success for China Exiting COVID-19 Social Distancing Policy After Achieving Containment

26 Mar, 2020 | 02:26h | UTC

Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment – Imperial College London (PDF)

See also: Summary

Commentaries: Initial success for COVID-19 social distancing in China – Imperial College London AND China shows way to ease lockdowns before vaccine, says report – The Guardian AND When can we let up? Health experts craft strategies to safely relax coronavirus lockdowns – STAT

Related: What China’s coronavirus response can teach the rest of the world – Nature AND Locked-down no longer, China’s Hubei begins return to normal – Reuters AND The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study – The Lancet Public Health

 


Randomized Trial: Aspirin Not Beneficial for Reducing the Risk of Dementia, MCI, or Cognitive Decline

26 Mar, 2020 | 02:20h | UTC

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline – Neurology (PDF)

Commentary: Study: An aspirin a day does not keep dementia at bay – American Academy of Neurology (free)

 


Analysis: What is the Risk of Dying from COVID-19?

26 Mar, 2020 | 02:23h | UTC

What do we know about the risk of dying from COVID-19? – Our World in Data

Related: Global Covid-19 Case Fatality Rates – Centre for Evidence-Based Medicine, University of Oxford (free)

 


Studies: Cardiac Injury Associated with Increased Mortality in Hospitalized Patients With COVID-19

26 Mar, 2020 | 02:21h | UTC

 


Study: Low Risk of Coronavirus Spreading Through Tears

26 Mar, 2020 | 02:10h | UTC

Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients – Ophthalmology

Commentary: Low risk of coronavirus spreading through tears – American Academy of Ophthalmology

 


Postacute Care Preparedness for COVID-19: Thinking Ahead

26 Mar, 2020 | 01:52h | UTC

Postacute Care Preparedness for COVID-19: Thinking Ahead – JAMA

“Post-acute care preparedness for COVID19: we need to strengthen capacity in primary and community care to deal with those discharged from hospital.” (via @trishgreenhalgh see Tweet)

 


Study: Prolonged Presence of SARS-CoV-2 Viral RNA in Fecal Samples

26 Mar, 2020 | 02:18h | UTC

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples – The Lancet Gastroenterology & Hepatology

“Very important article about viral shedding. Spoiler alert: quarantine may need to be much longer than 14 days. Virus is detectible in feces for up to 5 weeks. Caveat: virus not necessarily viable” (via @figgyjam see Tweet)

 


WHO Guidance: Maintaining a Safe and Adequate Blood Supply During the Pandemic Outbreak of COVID-19

26 Mar, 2020 | 02:08h | UTC

Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19) – World Health Organization

 


Preprint: To Stop COVID-19, Test Everyone, Repeatedly

26 Mar, 2020 | 01:50h | UTC

To stop COVID-19, test everyone, repeatedly – Medium

 


CEBM: Assessing Dyspnea by Telephone or Video

26 Mar, 2020 | 01:42h | UTC

Are there any evidence-based ways of assessing dyspnoea (breathlessness) by telephone or video – CEBM University of Oxford

 


Practical Advice: PPE Pearls

26 Mar, 2020 | 01:49h | UTC

Personal Protective Equipment (PPE) Pearls – COVID-19 – emDocs

 


Study: Persistence of Coronaviruses on Inanimate Surfaces and Their Inactivation with Biocidal Agents

26 Mar, 2020 | 02:06h | UTC

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents – The Journal of Hospital Infection

Commentaries: Coronavirus: household cleaning products can kill the virus – an expert on which ones to use – The Conversation AND One graphic shows how long the coronavirus lives on surfaces like cardboard, plastic, and steel – Business Insider

Related Study: Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 – New England Journal of Medicine

 


COVID Ethics: Should clinicians see patients without appropriate PPE?

26 Mar, 2020 | 01:48h | UTC

COVID Ethics: Should clinicians see patients without appropriate PPE? – First10EM

See also: COVID-19: Updates in Bioethics

 


Hydroxychloroquine: Small Study Shows No Benefit

26 Mar, 2020 | 01:39h | UTC

A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19) – Journal of Zhejiang University (abstract)

Commentary: Chloroquine Use For COVID-19 Shows No Benefit In First Small—But Limited—Controlled Trial – Forbes

Related: Coronavirus treatment hype can lead to harm – Lown Institute AND No, These Medicines Cannot Cure Coronavirus – The New York times

See also: Chloroquine for COVID-19: Cutting Through the Hype

 


Covid-19: A Remote Assessment in Primary Care

26 Mar, 2020 | 01:45h | UTC

Covid-19: a remote assessment in primary care – The BMJ

 


Study Estimates Impact of Social Distancing on Reducing Spread of COVID-19

25 Mar, 2020 | 02:51h | UTC

Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study – The Lancet Infectious Diseases

Commentaries: Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19 – The Lancet AND Scientific and ethical basis for social-distancing interventions against COVID-19 – The Lancet Infectious Diseases AND Study: Social distancing might reduce COVID-19 spread by as much as 99% – UPI

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.